thumbnail
Deal MakingBioNTech inks $250m deal with Autolus to develop CAR-T assetsBioNTech inks $250m deal with Autolus to develop CAR-T assets
BioNTech will purchase $200 million of Autolus Therapeutics’ shares in a private placement to advance both companies autologous CAR-T programs to commercialization.